Ticagrelor 60 mg vs. 90 mg in elderly ACS patients with vs. without diabetes undergoing percutaneous coronary intervention

19 February 2026 (15:45 - 16:45)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Angelo Laino

University of Naples Federico II, Naples (Italy)

6 More presentations in this session

Presentation thumbnail

Early oral anticoagulation monotherapy after PCI: insights from the POEM trial

Doctor C. Pivato (Milan, IT)

Abstract Slides

Presentation thumbnail

Utilisation and outcomes of dual antiplatelet therapy in patients with active cancer presenting with acute myocardial infarction: insights from the TriNetX global registry

Doctor A. Cole (Stoke on Trent, GB)

Abstract Slides

Presentation thumbnail

6 to 12-month vs. 1-month dual antiplatelet therapy: comparative outcomes after aspirin cessation with HT supreme stent in the pooled PIONEER III and PIONEER IV trial analysis

Professor Y. Onuma (Galway, IE)

Abstract Slides

Presentation thumbnail

Do the ARC-HBR criteria predict major bleeding and ischaemic events in an all-comer AMI population? Insights from the MINAP and SWEDEHEART registries

Doctor N. Weight (Stoke-on-Trent, GB)

Abstract Slides

Presentation thumbnail

One-month DAPT after biodegradable-polymer everolimus-eluting stent implantation in diabetic patients at high-bleeding risk: insights from the POEM trial

Doctor L. Gramss (Milan, IT)

Abstract Slides

Access the full session

Session thumbnail

Tailoring antithrombotic therapy after PCI: balancing ischaemic and bleeding risks

The Event

Event poster

EAPCI Summit 2026

19 February 2026 15:45 CET

You may be interested in

Webinar

Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients

ESC TV Today

Episode 7: Coronary spasm - Sex differences in heart failure

Congress Session

Challenges in hypertension management

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources